S. Falk

951 total citations
28 papers, 746 citations indexed

About

S. Falk is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Falk has authored 28 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Falk's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). S. Falk is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). S. Falk collaborates with scholars based in United Kingdom, United States and Switzerland. S. Falk's co-authors include Meyer Alpert, David Sebag‐Montefiore, Rob Glynne‐Jones, Tim Maughan, N. M. Bleehen, R. Ward, Jane Blazeby, Helen Meadows, Julian Abel and Suzanne Audrey and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S. Falk

28 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Falk United Kingdom	13	329	315	293	93	82	28	746
Th. Wiggers Netherlands	18	440 1.3×	416 1.3×	156 0.5×	128 1.4×	52 0.6×	40	998
Marina Djurfeldt Canada	13	457 1.4×	161 0.5×	236 0.8×	47 0.5×	74 0.9×	32	1.1k
Divya Khosla India	14	168 0.5×	191 0.6×	257 0.9×	63 0.7×	106 1.3×	91	762
Wolfgang Fiebiger Austria	20	592 1.8×	361 1.1×	382 1.3×	44 0.5×	54 0.7×	38	1.1k
Núria Laínez Spain	16	327 1.0×	432 1.4×	672 2.3×	76 0.8×	69 0.8×	77	1.1k
Kelsey C. Stoltzfus United States	12	360 1.1×	136 0.4×	224 0.8×	74 0.8×	36 0.4×	17	745
Ida Colantonio Italy	14	267 0.8×	123 0.4×	204 0.7×	32 0.3×	56 0.7×	39	596
Andrea Lo Canada	17	166 0.5×	177 0.6×	232 0.8×	64 0.7×	48 0.6×	65	796
S. Tashiro Japan	11	278 0.8×	288 0.9×	164 0.6×	68 0.7×	51 0.6×	48	599
M. R. Mahoney United States	13	721 2.2×	139 0.4×	198 0.7×	114 1.2×	56 0.7×	30	1.0k

Countries citing papers authored by S. Falk

Since Specialization

Citations

This map shows the geographic impact of S. Falk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Falk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Falk more than expected).

Fields of papers citing papers by S. Falk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Falk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Falk. The network helps show where S. Falk may publish in the future.

Co-authorship network of co-authors of S. Falk

This figure shows the co-authorship network connecting the top 25 collaborators of S. Falk. A scholar is included among the top collaborators of S. Falk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Falk. S. Falk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bridgewater, John, S. Pugh, Amy Whitehead, et al.. (2017). Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial. Annals of Oncology. 28. v162–v162. 3 indexed citations

Cunningham, David, Ruth E. Langley, Matthew Nankivell, et al.. (2015). LBA-03 Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). Annals of Oncology. 26. iv117–iv117. 7 indexed citations

Cunningham, David, Sally Stenning, Leanne Stevenson, et al.. (2015). 2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948). European Journal of Cancer. 51. S400–S400. 23 indexed citations

Sen, Neilayan, S. Falk, & Ross A. Abrams. (2014). Role of Chemoradiotherapy in the Adjuvant and Neoadjuvant Settings for Resectable Pancreatic Cancer. Clinical Oncology. 26(9). 551–559. 12 indexed citations

Seymour, Michel, Susan D. Richman, Gary Middleton, et al.. (2011). Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC).. Journal of Clinical Oncology. 29(15_suppl). 3523–3523. 19 indexed citations

Okines, Alicia, Lindsay C Thompson, SP Stenning, et al.. (2011). Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ) adenocarcinoma.. Journal of Clinical Oncology. 29(15_suppl). 4092–4092. 3 indexed citations

Mukherjee, Somnath, Chris Hurt, Gareth Griffiths, et al.. (2010). A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer.. Journal of Clinical Oncology. 28(15_suppl). TPS222–TPS222. 1 indexed citations

Audrey, Suzanne, Julian Abel, Jane Blazeby, S. Falk, & Rona Campbell. (2008). What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study. BMJ. 337(jul31 3). a752–a752. 90 indexed citations

Glynne‐Jones, Rob, S. Falk, Tim Maughan, Helen Meadows, & David Sebag‐Montefiore. (2007). A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study. British Journal of Cancer. 96(4). 551–558. 43 indexed citations

10.

Avery, Kerry, Chris Metcalfe, C P Barham, et al.. (2007). Quality of life during potentially curative treatment for locally advanced oesophageal cancer. British journal of surgery. 94(11). 1369–1376. 62 indexed citations

11.

Glynne‐Jones, Rob, David Sebag‐Montefiore, Tim Maughan, S. Falk, & Alec McDonald. (2005). A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Annals of Oncology. 17(1). 50–56. 68 indexed citations

12.

Sebag‐Montefiore, David, Rob Glynne‐Jones, S. Falk, Helen Meadows, & Tim Maughan. (2005). A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. British Journal of Cancer. 93(9). 993–998. 82 indexed citations

13.

Glynne‐Jones, Rob, et al.. (2005). Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC). Journal of Clinical Oncology. 23(16_suppl). 3527–3527. 15 indexed citations

14.

Blazeby, Jane, J. Nicklin, C P Barham, S. Falk, & Derek Alderson. (2002). Upper GI 26. British journal of surgery. 89(S1). 63–64. 1 indexed citations

15.

Clarke, Linda, Arnon Krongrad, Bruce L. Dalkin, et al.. (1997). Decreased incidence of prostate cancer with selenium supplementation. European Journal of Cancer Prevention. 6(5). 497–497. 3 indexed citations

16.

Ford, James M., et al.. (1997). A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clinical Oncology. 9(1). 20–24. 34 indexed citations

17.

Falk, S., Jonathan Ramsay, R. Ward, et al.. (1994). BW12C perturbs normal and tumour tissue oxygenation and blood flow in man. Radiotherapy and Oncology. 32(3). 210–217. 17 indexed citations

18.

Falk, S., Tim Maughan, Alan Lamont, et al.. (1993). Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer. Clinical Oncology. 5(2). 85–88. 7 indexed citations

19.

Falk, S., R. Ward, & N. M. Bleehen. (1992). The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography. British Journal of Cancer. 66(5). 919–924. 110 indexed citations

20.

Ramsay, Jonathan, N M Bleehen, Ian F. Dennis, et al.. (1992). Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer. International Journal of Radiation Oncology*Biology*Physics. 22(4). 721–725. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact